NOVO — April 2021
-
JPMorgan har kigget nærmere på GLP-1 markedet hos Novo. Undersøgelsen efterlader analytikeren med større tiltro end tidligere omkring Novo’s stærke globale position på området.
JPMorgan tilføjer, at konsensus forventningen til EPS for 1. kvartal for Novo virker for lav.
Banken gentager anbefalingen på overvægt og fastholder et kursmål på 500 kr. -
Test
-
Test
-
Helge du lyder snart som WHO: test test test:)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind